0008-0100 is the NDC code for Besponsa (generic drug) Inotuzumab ozogamicin Injection, powder, lyophilized, for solution, Intravenous by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., 0.25, mg/mL, CD22-directed Immunoconjugate (EPC),CD22-directed Antibody Interactions (MoA),Decreased DNA Integrity (PE),Increased Cellular Death (PE),Immunoconjugates (CS)
Frequently asked questions about NDC code 0008-0100
Here are some FAQ's about 0008-0100.
- What does 0008-0100 and other NDC codes mean?
User experience with 0008-0100
External - NDC code 0008-0100, and others
List of National Drug (NDC) Codes